Please login to the form below

Not currently logged in
Email:
Password:

ICOs

This page shows the latest ICOs news and features for those working in and with pharma, biotech and healthcare.

GSK discontinues two feladilimab trials in head and neck cancer

GSK discontinues two feladilimab trials in head and neck cancer

Feladilimab aims to selectively enhance T cell function by stimulating ICOS, a protein found on the surface of certain T cells often found on a number of solid tumours. ... In November 2020, Jounce Therapeutics also announced that it would not expand a

Latest news

More from news
Approximately 2 fully matching, plus 18 partially matching documents found.

Latest Intelligence

  • Happy 70th birthday NHS: the next 70 need to be very different Happy 70th birthday NHS: the next 70 need to be very different

    Key to the future of the health service in England will be the Integrated Care Organisations (ICOs), which aim to bring together health and social care services, both to improve patient ... At the moment there are 12 million people in England covered by

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    ICOs (formerly known as Accountable Care Systems) require exceptional individuals who can break down the many institutional, cultural and financial barriers between hospitals, primary care and local authorities.

  • Deal Watch July 2016 Deal Watch July 2016

    It is a humanised inducible co-stimulator (ICOS) agonist antibody, designed to both stimulate T effector cells and selectively reduce intra-tumoural T regulatory cells.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...